Literature DB >> 2831653

Evidence that the gene for herpes simplex virus type 1 DNA polymerase accounts for the capacity of an intertypic recombinant to spread from eye to central nervous system.

S P Day1, R N Lausch, J E Oakes.   

Abstract

HSV-1(17) replicates 100-fold more efficiently than HSV-2(186) within trigeminal ganglia following ocular infection. In order to identify the nucleotide sequences responsible for the differences in the capacity of the two HSV strains to grow within the peripheral nervous system, an intertypic recombinant was generated by infecting neuroblastoma cells with HSV-2(186) and a HSV strain possessing nucleotide sequences from HSV-1(17). The genome of the intertypic recombinant was composed entirely of HSV-2(186) DNA except for 2.0 kb of HSV-1(17) DNA positioned between m.u. 0.413 and 0.426. Following corneal infection of mice, the intertypic recombinant grew to higher titers in both ocular tissues and trigeminal ganglia than did the HSV-2 parent. Most significantly, the intertypic recombinant could spread into the brain from the trigeminal ganglion and kill the host whereas mice inoculated with the HSV-2(186) parent survived infection. The 2.0 kb of HSV-1(17) DNA inserted into the genome of the intertypic recombinant encodes the 5' terminus of the HSV-1 gene for DNA polymerase. Thus, the results suggest that the difference in the capacity of two HSV strains to replicate within the trigeminal ganglion of its host and to spread into the brain is determined by nucleotide sequences within the gene for DNA polymerase.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2831653     DOI: 10.1016/0042-6822(88)90243-7

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  6 in total

1.  Complementary lethal invasion of the central nervous system by nonneuroinvasive herpes simplex virus types 1 and 2.

Authors:  Y Nishiyama; H Kimura; T Daikoku
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

2.  Neuroattenuation of an avirulent bunyavirus variant maps to the L RNA segment.

Authors:  M J Endres; C Griot; F Gonzalez-Scarano; N Nathanson
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

3.  Polygenic control of neuroinvasiveness in California serogroup bunyaviruses.

Authors:  C Griot; A Pekosz; D Lukac; S S Scherer; K Stillmock; D Schmeidler; M J Endres; F Gonzalez-Scarano; N Nathanson
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

4.  Neurovirulence of herpes simplex virus types 1 and 2 isolates in diseases of the central nervous system.

Authors:  T Bergström; K Alestig; B Svennerholm; P Horal; B Sköldenberg; A Vahlne
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-10       Impact factor: 3.267

5.  Differences in pathogenicity of herpes simplex virus serotypes 1 and 2 may be observed by histopathology and high-resolution magnetic resonance imaging in a murine encephalitis model.

Authors:  H C Thomas; R D Kapadia; G I Wells; A M Gresham; D Sutton; H A Solleveld; S K Sarkar; S B Dillon; R Tal-Singer
Journal:  J Neurovirol       Date:  2001-04       Impact factor: 2.643

6.  Ocular avirulence of a herpes simplex virus type 1 strain is associated with heightened sensitivity to alpha/beta interferon.

Authors:  Y H Su; J E Oakes; R N Lausch
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.